10X Genomics Inc

NASDAQ TXG

Data sourced from iex and EODHD
Download Data

10X Genomics Inc Income Statement 2018 - 2024

This table shows the Income Statement for 10X Genomics Inc going from 2018 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Revenue
M 141 184 154 147 134 156 131 115 114 144 125 116 106 112 72 43 72 75 61 56 54 51 37 32 30
Cost of Revenue
M 45 78 58 47 36 37 30 28 25 28 25 5 17 19 14 10 15 17 15 15 14 15 5 5 4
Gross Profit
M 96 106 96 100 98 119 101 87 89 116 101 111 89 93 57 33 57 59 46 41 40 36 31 27 25
Operating Expenses
M 155 142 190 163 150 143 141 150 131 132 117 121 99 503 123 72 77 67 55 51 43 111 46 33 33
Selling, General, and Administrative Expenses (SG&A)
M 86 83 82 92 83 79 73 79 67 70 62 69 57 56 52 44 50 39 33 33 27 23 19 21 21
Research and Development (R&D) Expenses
M 68 56 108 71 67 64 67 71 64 62 55 53 42 40 30 28 26 28 22 18 15 13 11 11 15
Other Operating Expenses
M 1 3 0 0 0 0 0 0 0 0 0 -1 0 407 41 0 0 0 0 1 1 75 16 0 -3
Costs and Expenses
M 110 64 132 116 114 106 110 122 105 104 92 117 82 77 67 62 61 50 39 36 28 25 25 28 32
Operating Income
M -59 -36 -95 -63 -52 -23 -40 -63 -42 -16 -16 -10 -10 -410 -65 -39 -20 -8 -9 -10 -3 -75 -15 -5 -7
Interest Expense
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 - -
Non-operating Income/Expense
M 2 -11 -1 -2 2 7 0 -1 0 0 -1 1 -1 -406 -41 0 -2 0 0 -1 -1 -71 -16 0 -3
EBT
M -58 -47 -92 -61 -50 -16 -40 -64 -42 -16 -17 -10 -11 -409 -65 -40 -21 -7 -10 -11 -4 -75 -15 -6 -11
Income Tax Provision
M 2 2 1 2 1 1 2 1 1 2 1 1 0 7 1 0 0 0 0 0 0 0 0 0 0
Income after Tax
M -60 -49 -93 -62 -51 -17 -42 -64 -42 -18 -17 -11 -12 -416 -66 -40 -21 -7 -10 -11 -4 -76 -15 -6 -11
Non-Controlling Interest
M - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - -
Net Income
M - - -93 -62 -51 -17 -42 -64 -42 -18 -17 -11 -12 -416 -66 -40 -21 -7 -10 -11 -4 -45 -15 - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 119,394,180.00 118,565,724.00 117,728,293.00 116,707,672.00 115,619,869.00 114,757,572.00 114,112,382.00 113,574,757.00 112,966,196.00 111,896,429.00 110,874,249.00 109,866,294.00 108,714,027.00 107,386,772.00 101,341,945.00 98,978,283.00 96,829,093.00 96,027,247.00 29,184,218.00 92,849,660.00 82,891,536.00 82,891,536.00 82,891,536.00 12,985,535.00 12,985,535.00
EBITDA
M -48 -24 -92 -61 -50 -16 -40 -64 -42 -16 -16 -11 -11 -1 -24 -39 -18 -6 -9 -8 -1 -3 2 -4 -6
Depreciation and Amortization
M 11 12 3 12 2 7 0 -1 0 7 7 7 6 5 5 4 4 3 2 1 1 1 1 1 1
EBIT
M -59 -36 -95 -73 -52 -23 -40 -63 -42 -23 -24 -18 -17 -6 -29 -44 -23 -9 -11 -10 -2 -4 1 -5 -7
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - 0 0 0 0 - -
Tax Rate (Effective)
% -3.71 -5.05 -1.35 -2.71 -2.20 -4.90 -4.69 -0.98 -1.72 -15.36 -3.14 -10.99 -3.91 -1.70 -0.90 -1.06 -1.43 -1.54 -0.08 -0.63 -0.94 -0.06 -0.10 -0.27 -0.13
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - -
Gross Profit Margin
% 67.78 57.65 62.18 67.85 73.27 76.43 76.82 75.83 77.75 80.77 80.43 95.76 83.88 83.16 79.93 76.57 78.99 77.98 74.71 73.12 73.94 70.53 85.68 85.67 85.60
Operating Income Margin
% -42.12 -19.36 -61.70 -43.15 -38.71 -14.78 -30.51 -55.07 -36.45 -11.03 -12.67 -8.92 -9.65 -364.99 -90.86 -91.88 -27.65 -10.73 -14.86 -18.56 -5.66 -148.29 -40.79 -17.17 -24.78
Net Income Margin
% - - -60.52 -42.51 -37.79 -11.02 -31.98 -56.24 -37.04 -12.85 -13.70 -9.54 -10.92 -370.33 -91.69 -93.62 -29.40 -9.48 -15.69 -19.49 -6.79 -89.87 -41.92 - -
EBITDA Ratio
% -33.97 -12.99 -59.71 -41.39 -36.96 -10.42 -30.46 -55.60 -36.30 -10.99 -13.11 -9.15 -10.12 -0.96 -33.27 -91.17 -25.53 -7.83 -14.52 -15.05 -2.04 -6.47 6.23 -13.76 -21.12
EBIT Ratio
% -42.12 -19.36 -61.70 -49.48 -38.71 -14.78 -30.51 -55.07 -36.45 -16.09 -18.92 -15.35 -16.23 -5.79 -40.07 -101.58 -31.46 -11.60 -17.85 -17.10 -3.97 -8.23 3.92 -17.17 -24.78
EBT Ratio
% -40.99 -25.33 -59.71 -41.39 -36.98 -10.50 -30.54 -55.69 -36.42 -11.14 -13.29 -8.60 -10.50 -364.13 -90.87 -92.63 -28.99 -9.33 -15.68 -19.37 -6.72 -149.31 -41.87 -18.61 -36.49

StockViz Staff

September 16, 2024

Any question? Send us an email